High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS…

Amount: up to $1.5M
Type: Grant

Key facts

Key facts for High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Amount	up to $1.5M
Issuer	National Institutes of Health
Who can apply	US companies
Sectors	EdTech · HealthTech
Deadline	Closes 05 Mar 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 21 hours ago

40 days agoagentImported from the official source

Opportunities with the same funding type or region
AI Growth Lab		Closes 27 Sep 2026
BJA FY 2026 Adult Treatment Court Program	up to $2.5M	Closes 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Cases	up to $450,000	Closes 29 Oct 2026